Analyst Ranking
Bottom 2%
#4800 out of 4875 analysts
Average Return
-12.12%
Win Rate
29%46 out of 157
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-20 -
2024-03-19
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-28 -
2025-02-27
Buy
Lifecore Biomedical IncLFCR
+54.15%$3.25$5.01
2023-03-21 -
2024-03-20
Buy
Lemaitre Vascular IncLMAT
+40.60%$71.06$99.91
2024-02-28 -
2025-02-27
Buy
Surmodics IncSRDX
+39.37%$30.10$41.95
2023-06-21 -
2024-06-20
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Henry Schein IncHSIC
14Buy$86.00+25.29%Maintains
5 days ago
Opko Health IncOPK
10Buy$2.25+81.45%Maintains
10 days ago
Option Care Health IncOPCH
15Buy$38.00+19.35%Maintains
11 days ago
Merit Medical Systems IncMMSI
20Buy$103.00+7.48%Maintains
16 days ago
Anika Therapeutics IncANIK
11Buy$20.00+71.82%Maintains
2 months ago
Verifyme IncVRME
9Buy$1.25+63.40%Maintains
2 months ago
Modivcare IncMODV
13Buy$6.00+412.82%Maintains
2 months ago
Dentsply Sirona IncXRAY
15Buy$20.00+26.50%Maintains
2 months ago
U S Physical Therapy IncUSPH
17Buy$98.00+32.31%Maintains
2 months ago
Haemonetics CorpHAE
17Buy$95.00+39.32%Maintains
3 months ago
Lemaitre Vascular IncLMAT
8Buy$93.00+15.87%Maintains
6 months ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
a year ago
Lifecore Biomedical IncLFCR
9Buy$10.00N/AMaintains
2 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
4 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.